Predictors of Success in Selective Laser Trabeculoplasty

被引:22
作者
Kuley, Brandon [1 ]
Zheng, Cindy X. [1 ]
Zhang, Qiang Ed [1 ,2 ]
Hamershock, Rose A. [1 ,2 ]
Lin, Michael M. [1 ]
Moster, Stephen J. [1 ]
Murphy, James [1 ]
Moster, Marlene R. [1 ]
Schmidt, Courtland [1 ]
Lee, Daniel [1 ]
Pro, Michael J. [1 ]
机构
[1] Wills Eye Hosp & Res Inst, Philadelphia, PA USA
[2] Wills Eye Hosp & Res Inst, Penn Biostat Consulting Core, Vickie & Jack Farber Vis Res Ctr, Philadelphia, PA USA
来源
OPHTHALMOLOGY GLAUCOMA | 2020年 / 3卷 / 02期
关键词
OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; VISUAL IMPAIRMENT; OUTCOMES;
D O I
10.1016/j.ogla.2019.11.010
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: Selective laser trabeculoplasty (SLT) is a common procedure to lower intraocular pressure (IOP) in patients with glaucoma. However, reports are conflicting regarding what factors contribute to SLT success. The purpose of this study was to determine predictors of SLT success. Design: Retrospective case series. Participants: All patients treated with SLT between January 1, 2012, and June 30, 2018. Methods: Baseline, demographic, procedural, and ophthalmic examination data were recorded at the time of first SLT treatment. Intraocular pressure and medication data were recorded at all follow-up visits. Main Outcome Measures: Selective laser trabeculoplasty success was defined as IOP decrease of 20% or more from baseline at the 3-month, 6-month, and 12-month follow-up visits. Eyes were considered to have failed and were censored when additional SLT or glaucoma surgery was performed. Patients were excluded if they had less than 3 months of follow-up. Results: A total of 997 eyes from 677 patients were included in the study. Mean age was 70.2 +/- 11.5 years. Selective laser trabeculoplasty success was achieved in 227 eyes (22.8%), whereas 770 eyes (77.2%) did not meet success criteria. Intraocular pressure before SLT was 21.9 +/- 5.2 mmHg while taking 2.0 +/- 1.2 medications in eyes with successful SLT, compared with 19.0 +/- 5.0 mmHg (P < 0.0001) while taking 2.1 +/- 1.3 medications (P = 0.52) in eyes with SLT failure. At the 1-year follow-up, mean IOP in eyes with SLT success was 14.7 +/- 3.2 mmHg with 2.0 +/- 1.2 medications, compared with 16.3 +/- 4.7 mmHg (P = 0.008) with a mean of 1.9 +/- 1.3 medications (P = 0.37) in eyes with SLT failure. Eyes with SLT success more often showed greater angle pigment (P = 0.03). Age, glaucoma severity, total SLT power, type of glaucoma, severity of glaucoma, visual field mean defect, and retinal nerve fiber layer thickness were not found to correlate with success. No difference was found between the rate of success based on treatments before SLT, whether surgical or medical. Conclusions: In this large cohort of eyes undergoing SLT, greater IOP and angle pigment before SLT correlated positively with SLT success. Age, total SLT power, severity of glaucoma, and prior treatments were not associated with SLT success or failure. (C) 2019 by the American Academy of Ophthalmology
引用
收藏
页码:97 / 102
页数:6
相关论文
共 25 条
  • [1] Diagnostic and surgical techniques - Selective laser trabeculoplasty
    Barkana, Yaniv
    Belkin, Michael
    [J]. SURVEY OF OPHTHALMOLOGY, 2007, 52 (06) : 634 - 654
  • [2] Baseline Factors Predictive of SLT Response: A Prospective Study
    Bruen, Robin
    Lesk, Mark R.
    Harasymowycz, Paul
    [J]. JOURNAL OF OPHTHALMOLOGY, 2012, 2012
  • [3] A comparison between 90° and 180° selective laser trabeculoplasty
    Chen, EP
    Golchin, S
    Blomdahl, S
    [J]. JOURNAL OF GLAUCOMA, 2004, 13 (01) : 62 - 65
  • [4] Selective laser trabeculoplasty for early glaucoma: analysis of success predictors and adjusted laser outcomes based on the untreated fellow eye
    Chun, Mikael
    Gracitelli, Carolina P. B.
    Lopes, Flavio S.
    Biteli, Luis G.
    Ushida, Michele
    Prata, Tiago S.
    [J]. BMC OPHTHALMOLOGY, 2016, 16 : 1 - 8
  • [5] Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial
    Gazzard, Gus
    Konstantakopoulou, Evgenia
    Garway-Heath, David
    Garg, Anurag
    Vickerstaff, Victoria
    Hunter, Rachael
    Ambler, Gareth
    Bunce, Catey
    Wormald, Richard
    Nathwani, Neil
    Barton, Keith
    Rubin, Gary
    Buszewicz, Marta
    Bourne, Rupert
    Broadway, David
    Bunce, Catey
    Buszewicz, Marta
    Davis, Amanda
    Jayaram, Hari
    Jiang, Yuzhen
    Lim, Sheng
    Liput, Joanna
    Manners, Timothy
    Morris, Stephen
    Strouthidis, Nicholas
    Wilson, Sarah
    Wormald, Richard
    Zhu, Haogang
    [J]. LANCET, 2019, 393 (10180) : 1505 - 1516
  • [6] Mechanism of Action of Selective Laser Trabeculoplasty and Predictors of Response
    Gulati, Vikas
    Fan, Shan
    Gardner, Bret J.
    Havens, Shane J.
    Schaaf, Marie T.
    Neely, Donna G.
    Toris, Carol B.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (03) : 1462 - 1468
  • [7] Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: results from a randomised clinical trial
    Hodge, WG
    Damji, KF
    Rock, W
    Buhrmann, R
    Bovell, AM
    Pan, Y
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2005, 89 (09) : 1157 - 1160
  • [8] Outcomes and Bleb-Related Complications of Trabeculectomy
    Jampel, Henry D.
    Solus, Jason F.
    Tracey, Patricia A.
    Gilbert, Donna L.
    Loyd, Tara L.
    Jefferys, Joan L.
    Quigley, Harry A.
    [J]. OPHTHALMOLOGY, 2012, 119 (04) : 712 - 722
  • [9] Jha Bhaskar, 2012, J Curr Glaucoma Pract, V6, P79, DOI 10.5005/jp-journals-10008-1111
  • [10] Selective Laser Trabeculoplasty Versus Medical Therapy as Initial Treatment of Glaucoma: A Prospective, Randomized Trial
    Katz, L. Jay
    Steinmann, William C.
    Kabir, Azad
    Molineaux, Jeanne
    Wizov, Sheryl S.
    Marcellino, George
    [J]. JOURNAL OF GLAUCOMA, 2012, 21 (07) : 460 - 468